Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2003
08/19/2003US6607755 Anti-aromatase pharmaceutical composition for controlling testosterone/estrone ratios
08/19/2003US6607753 Converting extract of Tribulus furostanol saponin compounds to spirostanol compounds; hydrolysis, separation; topical application
08/19/2003US6607752 Forming a nicotine/cation exchange resin solvent mixture by blending nicotine, resin and solvent together, maintaining the solvnet in liquid state for a second by controlling pressure and temperature, then evaporation the solvent
08/19/2003US6607750 Directly compressible acetaminophen compositions
08/19/2003US6607749 Non-fermentable methyl cellulose, lipase inhibitor and edible calcium phosphate salt; fecal incontinence, obesity
08/19/2003US6607748 Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
08/19/2003US6607745 Ingestion of hyaluronic acid for improved joint function and health
08/19/2003US6607743 Milk-derived basic cystatins or decomposition products; foods, beverages, feeds
08/19/2003US6607742 Suppository composition which is a spray-dried suspension of an acid-labile proton pump inhibitor in a solvent solution of a sterol and polymer
08/19/2003US6607741 Conjugates of sodium channel blockers and methods of using the same
08/19/2003US6607735 Method for reducing the appearance of dark circles under the eyes
08/19/2003US6607730 Chlamydia antigens and corresponding DNA fragments and uses thereof
08/19/2003US6607715 Feasible fatty ammonium quat compound or composition useful in hair products and the like comprising the properties of being flakeable and having at least 35% cationic activity.
08/19/2003US6607710 Provide a bisphosphonic acid derivative and said bisphosphonic acid derivative being labeled with a radioactive nuclide, which has properties of rapid accumulation to the bone and rapid urinary excretion.
08/19/2003US6607382 Methods and systems for concurrent tooth repositioning and substance delivery
08/19/2003CA2299972C Thyromimetic antiobesity agents
08/19/2003CA2276324C Loratadine for use as an antiarrhythmic
08/19/2003CA2260337C Therapeutic agents
08/19/2003CA2138149C Stables compositions of microgranules of gastro-protected omeprazole and process for their preparation
08/19/2003CA2133830C Micromechanical thermoelectric sensor element
08/19/2003CA2116967C Antidepressants
08/19/2003CA2100777C Pharmaceutical composition containing granisetron and dexamethasone
08/19/2003CA2099867C 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
08/19/2003CA2099061C Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis
08/19/2003CA2091165C Polymers containing diester units
08/19/2003CA2086207C Process for preparing optionally hydrogenated indigestible polysaccharides
08/19/2003CA2085347C Novel cyclic aminophenylacetic acid derivative, production therof, and immune response modulator containing the same as active ingredient
08/19/2003CA2079376C (bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
08/19/2003CA2079375C (hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
08/19/2003CA2067404C Benzoisothiazole and benzoisoxazole-3-carboxamides a process for their preparation and their use as medicaments
08/19/2003CA2043077C Prostaglandin analogues for use in medicine
08/19/2003CA2033122C Anti-inflammatory analgesic patch
08/18/2003CA2372538A1 Antitussive/antihistaminic/decongestant compositions
08/18/2003CA2372535A1 Antitussive compositions
08/14/2003WO2003067209A2 Ligands to enhance cellular uptake of biomolecules
08/14/2003WO2003066889A2 Assay for acytyltransferase or deacetylase activity
08/14/2003WO2003066881A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/14/2003WO2003066860A1 Angiogenesis inhibitors
08/14/2003WO2003066859A2 Amino acid sequences capable of facilitating penetration across a biological barrier
08/14/2003WO2003066842A2 Method for producing recombinant proteins in micro-organisms
08/14/2003WO2003066841A1 Viral variants with altered susceptibility to nucleoside analogs and uses thereof
08/14/2003WO2003066840A2 Pluripotent embryonic-like stem cells derived from teeth and uses thereof
08/14/2003WO2003066813A2 MINRs AS MODIFIERS OF INSULIN RECEPTOR SIGNALING AND METHODS OF USE
08/14/2003WO2003066810A2 Recombinant bovine immunodeficiency virus based gene transfer system
08/14/2003WO2003066806A2 Therapeutic use of aziridino compounds
08/14/2003WO2003066679A1 Rhamnose binding protein
08/14/2003WO2003066659A2 Improved method for obtaining betulinic acid
08/14/2003WO2003066656A1 Crystalline complexes of fluticasone 2-furoate
08/14/2003WO2003066655A1 Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form
08/14/2003WO2003066650A2 Short interfering rna molecules directed towards a tissue factor coding nucleic acid
08/14/2003WO2003066638A2 The synthesis of naturally occuring ecteinascidins and related compounds
08/14/2003WO2003066637A1 Polymorphs of clopidogrel hydrochloride and their use as antithrombic compounds
08/14/2003WO2003066636A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/14/2003WO2003066635A1 Piperidine derivatives
08/14/2003WO2003066634A1 Substituted fused pyrazolecarboxylic acid arylamides and related compounds
08/14/2003WO2003066633A1 Novel pyranosyl cytosines: pharmaceutical formulations and methods
08/14/2003WO2003066632A1 Sulphonyl compounds with 5 -ht6 receptor affinity
08/14/2003WO2003066631A1 Antimicrobial thiadiazinone derivatives useful in treatment of bacterial infections
08/14/2003WO2003066630A2 Quinolinone derivatives for treating cell proliferation related disorders
08/14/2003WO2003066629A2 Heteroaryl compounds useful as inhibitors of gsk-3
08/14/2003WO2003066623A1 Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders
08/14/2003WO2003066621A1 Piperidine derivatives and their use as antagonists of tachykinins
08/14/2003WO2003066620A1 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent
08/14/2003WO2003066618A1 Cytoprotective benzofuran derivatives
08/14/2003WO2003066613A1 N-phenyl-2-pyrimidine-amine derivatives
08/14/2003WO2003066612A1 Novel polymorphic forms of bicyclic antidiabetic agents: process for their preparation and pharmaceutical compositions containing them
08/14/2003WO2003066608A1 Catechol bioisosteres
08/14/2003WO2003066606A1 Salts of valsartan
08/14/2003WO2003066604A2 Novel aryl- and heteroarylpiperazines
08/14/2003WO2003066603A1 Quinazolinone derivatives and their use as cb agonists
08/14/2003WO2003066601A1 Pyrimidine compounds
08/14/2003WO2003066599A1 N-allyloxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use of the same as pharmaceuticals
08/14/2003WO2003066596A1 Pyridineamido derivatives as inhibitors of monoamine oxidase (mao-b)
08/14/2003WO2003066595A2 2 - piperazine - pyridines useful for treating pain
08/14/2003WO2003066594A2 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
08/14/2003WO2003066593A2 Preparation of pharmaceutical salts of 4 ( (z) - (4-bromophenyl) (ethoxyimino) methyl )-1'-( (2,4-dimethyl-1-oxido-3-pyridinyl) carbonyl) -4'-methyl-1,4' bipiperidine as ccr5-antagonists for the treatment of aids and related hiv infections
08/14/2003WO2003066592A1 Gamma secretase inhibitors
08/14/2003WO2003066591A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient
08/14/2003WO2003066590A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient
08/14/2003WO2003066589A1 Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
08/14/2003WO2003066588A1 Water soluble phenylglycine derivatives
08/14/2003WO2003066587A2 Piperidine or pyrrolidine derivatives having an aminoacyl substituted side chain as melancortin-4 receptor agonists
08/14/2003WO2003066581A1 Urea linker derivatives for use as ppar modulators
08/14/2003WO2003066579A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
08/14/2003WO2003066577A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
08/14/2003WO2003066572A1 Polyamine compounds and compositions for use in conjunction with cancer therapy
08/14/2003WO2003066561A1 Novel 3-aryl-2,5-dihydroxy-1,4-benzoquinone derivatives, their preparation method and pharmaceutical compositions containing same
08/14/2003WO2003066205A2 Microcapsules having high carotenoid content
08/14/2003WO2003066186A2 Integration of at least two processes to re-use acid
08/14/2003WO2003066165A1 Tumor necrosis factor combined with interferon in demyelinating diseases
08/14/2003WO2003066104A2 Pharmaceutical composition which improves in vivo gene transfer
08/14/2003WO2003066103A1 Pharmaceutical compositions for hepatitis c viral protease inhibitors
08/14/2003WO2003066101A1 Preparation for oxidation-sensitive compounds and method for making same
08/14/2003WO2003066100A1 Hair growth stimulants, percutaneous preparations and method of stimulating hair growth
08/14/2003WO2003066099A1 2,4,6-triamino-1,3,5-triazine derivative
08/14/2003WO2003066091A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7
08/14/2003WO2003066087A2 Kinases involved in the regulation of energy homeostasis
08/14/2003WO2003066086A2 Proteins involved in the regulation of energy homeostatis
08/14/2003WO2003066077A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
08/14/2003WO2003066071A1 Formulations comprising psychotropic drugs and selenium
1 ... 5373 5374 5375 5376 5377 5378 5379 5380 5381 5382 5383 5384 5385 5386 5387 5388 5389 5390 5391 5392 5393 ... 7860